Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
suppliDerm is an oral protein-rich nutritional supplement developed by sanaFactur for nutritional support in patients with chronic or slow-healing wounds and for perioperative recovery support. It is formulated as a multi-ingredient combination of vitamins and minerals, including vitamin C, vitamin B12, folic acid, magnesium, and zinc, together with a proprietary blend of amino acids and proteins from slowly and quickly digestible protein sources. Rather than acting through a single pharmacologic target, it is intended to support wound healing biology and recovery by improving protein and micronutrient availability for tissue regeneration, immune function, and energy metabolism. It is marketed as a food supplement rather than a pharmaceutical drug, and related product variants include higher-protein and pre-surgical versions such as suppliDerm PLUS and suppliDerm PREP.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on suppliDerm.